Brief: RegeneRx Issues Advisory On Dry Eye Trial Amid COVID-19 Virus

RegeneRx Biopharmaceuticals

18/03/2020 14:17

March 18 (Reuters) - RegeneRx Biopharmaceuticals Inc
 RGRX.PK :
    * REGENERX ISSUES ADVISORY ON DRY EYE TRIAL AMID COVID-19
VIRUS
    * REGENERX - GTREEBNT TEAM MET CONTRACT RESEARCH
ORGANIZATION
MANAGING ARISE-3 TRIAL, TO DISCUSS CHANGES IN ENROLLMENT
ASSOCIATED WITH COVID-19 VIRUS
    * REGENERX - GTREEBNT,CRO CONTINUE WORKING TO ACHIEVE GOAL
OF
COMPLETING ARISE-3 TRIAL, OBTAINING RESULTS WITHIN INITIAL
PLANNED SCHEDULE
    * REGENERX BIOPHARMACEUTICALS - TO DATE, THERE HAS BEEN
LITTLE TO
NO EFFECT ON ENROLLMENT & CONTINUED TREATMENT OF DRY EYE
PATIENTS ENTERED INTO TRIAL

Source text for Eikon:  ID:nPn2b7rFFa 
Further company coverage:  RGRX.PK 

 ((Reuters.Briefs@thomsonreuters.com;))